Latest Listings And Ipos News

Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.

StepChange Holdings has locked in $11 million in new debt facilities with Westpac, enhancing its financial flexibility to accelerate growth and strategic acquisitions.

NRW Holdings showcased strong FY25 proforma results and ambitious FY26 guidance at the UBS Conference, underpinned by strategic acquisitions and a diversified portfolio. The company’s growth strategy focuses on expanding capabilities in energy transition and infrastructure markets across Australia, New Zealand, and North America.

MA Financial Group advances exclusive due diligence on a major Queensland retail asset and prepares a new ASX-listed credit notes offer, signaling strategic growth moves.

Sparc Technologies teams up with Dulux Australia to apply their graphene-enhanced ecosparc® coating on the heritage-listed Cape Jaffa Lighthouse, marking a key step in commercialising advanced protective coatings.

Ballard Mining Limited has released a comprehensive investor update following its July 2025 IPO, highlighting a robust 1.1 million ounce gold resource at Mt Ida and a strong cash position of $40 million. The company outlines ambitious exploration targets and development plans aiming to extend mine life beyond a decade.

New Frontier Minerals has secured regulatory approval to launch its first reverse circulation drilling campaign at the Harts Range Heavy Rare Earth and Niobium Project, while also preparing for a US OTCQB listing to broaden investor reach.

Mandrake Resources has signed a term sheet with DISA Technologies to explore recovering uranium and critical minerals from abandoned mine waste in Utah, leveraging a unique US regulatory license and strong government backing.

8I Holdings Limited has reported a remarkable 255% surge in net profit for the half-year ending September 2025, yet it has chosen not to declare any dividends. Investors are left weighing strong gains against cautious capital management.

Perpetual Credit Income Trust (PCI) has announced a $267 million entitlement and shortfall offer priced at $1.10 per unit, aiming to bolster its investment capacity in Australian credit markets. The offer presents a 9.1% discount to recent trading prices and is designed to enhance liquidity and scale for existing and new investors.

Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.

Gladiator Resources has provided detailed clarifications to the ASX regarding its agreement with Apex USA Resources LLC for rare earth tenements in California, highlighting ongoing disputes and incomplete project milestones.